针对残留炎症风险:动脉样硬化治疗和预防的下一个前沿
1From the Center for Cardiovascular Disease Prevention, Division of Preventive Medicine and the Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Vascular pharmacology
|October 23, 2023
概括
低剂量胆固醇可显著降低残留炎症风险的患者的心血管事件,即使在最佳的他类药物治疗中. 这种抗炎方法提供了一种新的策略来管理动脉样硬化症,而不仅仅是降低胆固醇.
科学领域:
- 心血管医学 心血管医学
- 炎症生物学 炎症生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 动脉样硬化是由炎症和高脂血症的协同作用驱动的.
- 降低低密度脂蛋白胆固醇 (LDLC) 和高敏感性C反应蛋白 (hsCRP) 都与改善的结果有关.
- 由hsCRP指出的残留炎症风险是复发性心血管事件的重要预测因素,即使在接受他类药物治疗的患者中也是如此.
研究的目的:
- 为了评估低剂量胆固醇作为对他类药物治疗的辅助药物的有效性,以减少心血管事件.
- 评估抗炎策略在控制动脉样硬化进展中的作用.
主要方法:
- 对接受他类药物治疗的患者低剂量胆固醇 (每天0.5毫克) 的随机试验数据的分析.
- 评估心血管事件发生率,包括心肌梗塞,中风和心血管死亡.
主要成果:
- 低剂量胆固醇显示,主要心血管不良事件减少了31%.
- 治疗与最小的副作用有关.
- 尽管接受了他类药物治疗,但仍存在残留炎症风险的患者观察到胆固醇的益处.
结论:
- 低剂量胆固醇是一种有效的辅助疗法,用于减少心血管事件.
- 准残留炎症风险对于治疗动脉样硬化至关重要.
- 科尔奇辛的批准意味着在心血管疾病管理中转向抗炎疗法.
相关概念视频
Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Atherosclerosis I: Introduction
9
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9
Atherosclerosis IV: Nursing Management
17
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
17
Inflammation
53.7K
Overview
53.7K
Coronary Artery Disease I: Introduction
17
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
17
Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11


